Back to ZBIO

Royalty Pharma Sub-Manager, LLC → ZBIO

Royalty Pharma Sub-Manager, LLC ZBIO Position History

Zenas BioPharma, Inc. • Healthcare

Quarters held
3
Latest value
$60.6M
Q2 2026
Peak value
$60.6M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$45.9M
Q1 2026$46.7M
Q2 2026$60.6M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q2 2026$60.6M2.39M——
Q1 2026$46.7M2.39M——
Q4 2025$45.9M1.26M——

Other funds holding ZBIO

Other Royalty Pharma Sub-Manager, LLC positions

CYTK

CYTOKINETICS, INC

$83.5M
CYTK

CYTOKINETICS, INC

$83.5M
CYTK

CYTOKINETICS, INC

$64.6M
CYTK

CYTOKINETICS, INC

$64.6M
CYTK

CYTOKINETICS, INC

$62.3M
CYTK

CYTOKINETICS, INC

$62.3M
BCAX

ZENAS BIOPHARMA, INC.

$60.6M
KLRA

KAILERA THERAPEUTICS

$54.1M